Guidelines versus individualized care for the management of CINV.

about

Evolving role of neurokinin 1-receptor antagonists for chemotherapy-induced nausea and vomiting

P2860

Q57483947-C2E9E4B4-6B76-4D9A-8539-1C812353ED73

P2860

Guidelines versus individualized care for the management of CINV.

Item

http://www.wikidata.org/entity/Q55336299

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Guidelines versus individualized care for the management of CINV.

@en

Guidelines versus individualized care for the management of CINV.

@nl

type

Item

label

Guidelines versus individualized care for the management of CINV.

@en

Guidelines versus individualized care for the management of CINV.

@nl

prefLabel

Guidelines versus individualized care for the management of CINV.

@en

Guidelines versus individualized care for the management of CINV.

@nl

P1476

Guidelines versus individualized care for the management of CINV

@en

P2093

Mark Clemons

http://www.w3.org/2001/XMLSchema#string

P2860

Results of a Southwest Oncology Group phase III trial of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide in advanced ovarian cancer.

The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting

Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity--an update.

Chemotherapy-Induced Nausea and Vomiting: Time for More Emphasis on Nausea?

Postoperative nausea and vomiting. Its etiology, treatment, and prevention.

Prospective validation of risk prediction indexes for acute and delayed chemotherapy-induced nausea and vomiting.

Symptom prevalence in patients with incurable cancer: a systematic review.

Efficacy of the neurokinin-1 receptor antagonist rolapitant in preventing nausea and vomiting in patients receiving carboplatin-based chemotherapy.

Use of conjoint analysis to assess breast cancer patient preferences for chemotherapy side effects.

Chemotherapy-induced nausea and vomiting: pathophysiology and therapeutic principles.

P2888

s00520-018-4115-3

P304

11-17

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00520-018-4115-3

http://www.w3.org/2001/XMLSchema#string

P433

Suppl 1

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mark Clemons

P577

2018-03-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1101626234

http://www.w3.org/2001/XMLSchema#string

P698

29556809

http://www.w3.org/2001/XMLSchema#string

P932

5876263

http://www.w3.org/2001/XMLSchema#string

Guidelines versus individualized care for the management of CINV.

about

P2860

P2860

Guidelines versus individualized care for the management of CINV.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932